Tatva Chintan approves September-quarter unaudited results
As filed · Tatva Chintan Pharma Chem Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
What happened
FactTatva Chintan Pharma Chem approved its standalone and consolidated unaudited financial results for the quarter and half year ended 30 September 2026. The results were reviewed by the Audit Committee and approved by the Board on 19 October 2026, with a limited review report from its statutory auditor enclosed.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
RevisedIt should contribute around INR70 crores to INR80 crores of revenue from all these pharma molecules.
We would be looking at somewhere around 1.2x to 1.5x asset turnover ratio, which means we would end up having around INR300 crores of revenue at peak utilization.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- It should contribute around INR70 crores to INR80 crores of revenue from all these pharma molecules. (management committed by FY27)
- None of them. We don't foresee any obstacles to this year's guidance because all the demand from the customers (management committed by FY27)
Evidence
- Tatva Chintan Pharma Chem Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The filing confirms completion of the company’s quarterly reporting process, but it does not provide the underlying financial results or operating figures in the text supplied.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%